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Glucose Reaction with Fumonisin B1 Partially Reduces Its
Toxicity in Swine
GUILLERMO FERNAÄ NDEZ-SURUMAY,† GARY D. OSWEILER,§ MICHAEL J. YAEGER,§
CATHERINE C. HAUCK,# SUZANNE HENDRICH,# AND PATRICIA A. MURPHY*,#
Interdepartmental Toxicology Program, Department of Veterinary Diagnostic and Production Animal
Medicine, and Department of Food Science and Human Nutrition, Iowa State University,
Ames, Iowa 50011
Acute and subacute intraperitoneal doses of fumonisin B1 (FB1) were administered to test the efficacy
of the FB1-glucose reaction products in detoxifying FB1 in swine. In the acute study at 11 ímol of
FB1/kg of body weight, five of six pigs administered FB1 and four of six pigs administered FB1-
glucose died from acute pulmonary edema. Analysis of weight gain, serum aspartate aminotransferase
and ç-glutamyltransferase, total cholesterol, and pathological evaluation did not provide evidence of
protection against FB1 toxicity by the FB1-glucose reaction products. In the subacute study at 5.5
ímol of FB1/kg of body weight, one pig administered FB1 died from liver damage. Analysis of serum
aspartate aminotransferase, ç-glutamyltransferase, and total bilirubin showed protection against FB1
toxicity by the FB1-glucose reaction products. The levels of sphinganine and sphinganine/sphingosine
ratios in serum and liver as well as pathologic findings provided definitive evidence of protection
against the FB1 toxic effects by this detoxification procedure (p < 0.05).
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INTRODUCTION
The fumonisins are a group of mycotoxins mainly produced
by the fungi Fusarium Verticillioides () F. moniliforme) and
Fusarium proliferatum in corn (1). Among other structurally
related homologues, fumonisin B1 (FB1) is the most abundant
natural contaminant of corn-based products intended for human
or animal consumption throughout the world (2). This mycotoxin
has been associated with a high incidence of human esophageal
cancer in some regions of China and the Transkei in South
Africa, where corn-based foods are the staple diet (3). Hence,
FB1 has been declared a class 2B carcinogen, a probable human
carcinogen (4). Fumonisin B1 has species-specific toxic effects.
In rodents, FB1 is hepatocarcinogenic, hepatotoxic, and neph-
rotoxic (5). Horses are the most sensitive species, known to
develop leukoencephalomalacia (ELEM) after consuming corn
contaminated with FB1 at levels >0.001 ímol/g (6, 7). In pigs,
subacute dietary levels, in the range of 0.1 ímol of FB1/g, can
cause liver disease in 15 days, whereas acute dietary levels,
>0.14 ímol of FB1/g, may produce fatal porcine pulmonary
edema (PPE) in <1 week (8, 9). In the United States, widespread
large-scale outbreaks of ELEM and PPE occurred during the
fall of 1989 and the winter of 1990. Significant numbers of
horses and pigs died from consuming commercial mixed feeds
containing FB1-contaminated corn (10).
Fumonisin B1 disrupts sphingolipid metabolism by potently
inhibiting the enzyme ceramide synthase (sphinganine N-
acetyltransferase) in the de noVo biosynthesis pathway of major
sphingolipids, thus causing a rapid increase in free sphinganine
(Sa), one of the base precursors (11, 12). The levels of free Sa
and sphingosine (So) in tissues and biological fluids may be
compared by constructing a ratio of Sa to So (Sa/So ratio) that
is used as an early biomarker of exposure to the mycotoxin
(13). The inhibition of ceramide synthase is also likely to disrupt
overall sphingolipid metabolism and, theoretically, sphingolipid-
mediated regulation of important cell events such as apoptosis
and mitosis, which are probably in part responsible for the
cytotoxic and carcinogenic properties of the mycotoxin (11, 14).
In swine, the animal model used in the present study, FB1
alters sphingolipid biosynthesis with the greatest alterations in
Sa and So concentrations occurring in kidneys, liver, lungs, and
heart (13). In a recent swine study, diets that were amended
with a fungal culture of F. Verticillioides to achieve FB1
concentrations of 0.006 and 0.01 ímol/g caused a significant
increase in the Sa/So ratio at days 15 and 8 of the study,
respectively (15). Serum markers of liver injury, such as
aspartate aminotransferase (AST), ç-glutamyltransferase (GGT),
total bilirubin (BIL), and total cholesterol (CHOL), increase after
exposure to either acute or subacute levels of FB1. Hepatic
lesions consist of apoptosis, necrosis, and hepatocyte prolifera-
tion (8, 9). The toxicological effects of feeding 0.04 ímol of
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FB1/g of feed to weaned piglets for 28 days were recently
evaluated. Animals presented typical signs of pulmonary edema
with reduced feed consumption and weight gain as well as
typical gross and microscopic lesions. Increases in erythrocyte
count, hematocrit, BIL, total protein, CHOL, and activities of
serum alkaline phosphatase (SAP), AST, and alanine amino-
transferase (ALT) were detected (16).
The primary amine group of FB1 has been suggested as the
site of toxicity for the molecule (17, 18). Detoxification of FB1
by blocking the amine group with a reducing sugar such as
fructose or glucose via the nonenzymatic browning (NEB) or
Maillard reaction has been suggested (19). This detoxification
strategy was used to demonstrate a significant reduction in
cancer promotion of diethylnitrosamine (DEN)-initiated Fis-
cher344/N rats treated with FB1-fructose when compared to
rats treated with FB1 alone (20). The effect of extrusion cooking
on the chemical recovery of FB1 was tested by HPLC analysis
of the FB1 amine. Results showed more apparent loss of the
FB1 amine in samples processed with mixing screws and heat
generated than with nonmixing screws. The brown color of
samples after extrusion suggested that loss of FB1 might be due
to the NEB reaction (21, 22). The products of the FB1-glucose
chain reaction were recently characterized as N-carboxymethyl-
fumonisin B1 (23, 24), N-(1-deoxy-D-fructos-1-yl)fumonisin B1,
N-methylfumonisin B1, N-(3-hydroxyacetonyl)fumonisin B1, and
N-(2-hydroxy-2-carboxyethyl)fumonisin B1 (24).
A recent study compared three groups of DEN-initiated
Fischer rats fed diets containing no FB1, highly purified FB1 at
0.03 ímol of FB1/g of feed, and FB1 reacted with glucose
containing a residual 0.01 ímol of FB1/g of feed, respectively.
The Sa/So ratio in the FB1-glucose group was the same as in
the controls, whereas the FB1 group presented a ratio that
indicated an alteration in the synthesis of complex sphingolipids
(25).
This study describes the effects of FB1-glucose reaction
products in swine using acute and subacute intraperitoneal (IP)
doses of FB1 in completely randomized designs. Toxicological
endpoints were defined as PPE and liver damage, respectively.
Our hypothesis was that the chemical reaction of FB1 with
glucose would decrease FB1 toxicity in swine. The goal was to
evaluate the efficacy of the FB1-glucose reaction products in
the detoxification of acute and subacute FB1 poisoning of swine.
MATERIALS AND METHODS
Preparation of Purified Fumonisin B1. Liquid cultures of F.
proliferatum strain M5991 were prepared following the method of
Dantzer et al. (26) by inoculating capped baffled Erlenmeyer flasks
containing 500 mL of modified Myro medium with a 4 day shake flask
culture of the fungus for 100 days. FB1 was isolated and purified to
>95% according to the procedure of Dantzer et al. (27).
Preparation of Fumonisin B1-Glucose Adducts. Two batches of
FB1-glucose adduct were prepared according to the method of Lu et
al. (24). Briefly, 1.39 mM FB1 (total ) 6.144 mmol or 4.435 g in the
acute toxicity study and 2.061 mmol or 1.488 g in the subacute toxicity
study) was mixed with 0.1 M D-glucose and dissolved in 50 mM
potassium phosphate buffer, pH 7.0. After incubation at 80 °C for 48
h for the acute toxicity study and for 200 h for the subacute toxicity
study, the pH of the reaction mixture was adjusted to pH 2.7 with 2 N
HCl to stop the reaction. The reaction was conducted for a longer time
in preparation for the subacute toxicity study to achieve 89% free amine
FB1 reduction by glucose. High-capacity C18 SPE cartridges (Alltech,
Deerfield, IL) were preconditioned with 50 mL of 100% methanol at
pH 2.7 followed by 100 mL of deionized water at pH 2.7. An aliquot
of 50 mL of the 1.39 mM FB1-0.1 M D-glucose reaction mixture was
loaded onto the cartridge. The cartridge was washed with 100 mL of
deionized water and 100 mL of 30% methanol at pH 2.7. The excess
D-glucose was washed out in this step. The FB1-glucose was eluted
with 50 mL of 40% methanol and 100 mL of 100% methanol at pH
2.7. The eluent was evaporated to dryness with a Brinkmann rotavapor
R110 (Westbury, NY) at 37 °C. The percentages of free and reacted
FB1 were determined according to the method of Dantzer et al. (27).
For the acute toxicity study, the residue was redissolved in 0.9% sterile
saline to obtain an FB1 concentration of 11 ímol/mL. For the subacute
toxicity study, the residue was redissolved in sterile 0.05 M potassium
phosphate buffer, pH 7.35, to achieve an FB1 concentration of 5.5 ímol/
mL. We used potassium phosphate buffer in the subacute toxicity study
after we determined it would improve the solubility of the FB1-glucose
residue compared to saline solution.
Experimental Animals. The use of animals and experimental
procedures were approved by the Iowa State University Laboratory
Animal Care Committee in 2000. In the acute toxicity study, 18 3-week-
old healthy pigs with initial body weights between 6.2 and 7.7 kg were
randomly assigned to three treatment groups (6 pigs/treatment), housed
in groups of 2 per pen, and allowed to acclimate to the animal room
for 3 days. Room temperature was maintained at 27 °C with water and
feed supplied ad libitum. In the subacute toxicity study, 12 3-week-
old pigs with initial body weights between 4.9 and 8.6 kg were divided
into similar treatment groups (4 pigs/treatment), individually housed
in pens, and exposed to the same conditions as in the acute toxicity
study.
Experimental Treatments. All doses were administered intraperi-
toneally (ip) once a day. Volume injected never exceeded 1 mL/kg of
body weight (BW) to minimize abdominal discomfort. Treatments
consisted of the vehicle, FB1, and the FB1-glucose reaction products
(FB1-G). In the acute toxicity study with PPE as endpoint, doses were
administered for a maximum of 9 days and were, in the control group,
1 mL of vehicle/kg of BW; in the FB1 group, 11 ímol of FB1/kg of
BW; and in the FB1-G group, 11 ímol of FB1-G/kg of BW. The FB1-G
products contained 30% unreacted FB1 determined by HPLC and
ELISA ) 3.3 ímol of FB1/kg of BW. In the subacute toxicity study
with liver damage as endpoint, doses were administered for a maximum
of 7 days and were in the control group, 1 mL of vehicle/kg of BW;
in the FB1 group, 5.5 ímol of FB1/kg of BW; and in the FB1-G group,
5.5 ímol of FB1-G/kg of BW. The FB1-G products contained 11%
unreacted FB1 determined by HPLC ) 0.6 ímol of FB1/kg of BW.
Diet. All pigs in the acute and subacute toxicity studies received
the same balanced diet consisting of weaning feed (Nevada Feed and
Seed Co., Nevada, IA) with the following proximate composition: dry
matter (88.8%), protein (18.76%), lysine (1.35%), fat (4.74%), fiber
(3.22%), calcium (0.91%), phosphorus (0.75%), salt (0.55%), zinc
(139.4 ppm), iodine (0.02 ppm), iron (19.8 ppm), copper (0.9 ppm),
manganese (3.42 ppm), selenium (0.28 ppm), and vitamin E (3.96 IU/
kg).
The general health of the swine was evaluated using a checkup list
form specifically designed to record simple clinical observation
parameters including behavior, mucous membrane coloration, respira-
tory rate (resp/min), heart rate (beats/min), and rectal temperature (°C)
on a daily basis.
Weight gain was calculated on day 3 of the acute study and on day
7 of the subacute study by subtracting initial body weight from final
body weight.
Clinical Chemistry. In the acute toxicity study, blood samples were
taken on days 0 and 3 by jugular venipuncture. In the subacute toxicity
study, pigs were bled from the orbital venous sinus on days 0, 4, and
7. Blood was allowed to clot for at least 45 min and then centrifuged
at 3100 rpm for 15 min to separate serum from the clot. All samples
were evaluated for serum chemistry analysis. The liver enzymes
aspartate aminotransferase (AST) and ç-glutamyltransferase (GGT),
total bilirubin (BIL), and total cholesterol (CHOL) were measured using
a programmable, automated clinical analyzer (Hitachi 912, Roche
Diagnostics, Basel, Switzerland). In the subacute toxicity study,
duplicate serum samples were stored at -20 °C for extraction and
HPLC analysis of sphingolipids.
Sphingolipid Analysis. The concentrations of Sa and So and their
ratio in serum and liver were measured only in the subacute toxicity
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study because tissues from acute toxicity study were lost in a freezer
failure. Extraction, internal standard curve, and HPLC analysis were
as follows.
The method in appendix 1 of Riley et al. (28) was followed with
some modifications. All samples were analyzed in triplicates. Three
hundred microliters of serum was added to 1.2 mL of cold 0.05 M
potassium phosphate buffer, pH 7.0, for homogenization. One hundred
microliters of the solution was transferred to a 13  1000 mm acid-
washed glass tube with a PTFE-faced, rubber-lined cap. Thirty
microliters of 5 íM d,l-erythro-C20-dihydrosphingosine (C-20, 150
pmol) internal standard was added. Samples were stirred every 15 min
during incubation. Centrifugation speed was 4000 rpm. The CHCl3
residue was dried at 37 °C under N2 using a nitrogen evaporator
(Organomation Associates, Inc., Berlin, MA). Samples were stored at
4 °C overnight. The next day, samples were base-hydrolyzed and
incubated at 37 °C for 1 h. Chloroform and alkaline water were added,
and then the samples were stirred and centrifuged at 4000 rpm for 15
min. The final CHCl3 residue was dried at 37 °C under N2 using a
nitrogen evaporator. Samples were stored at -80 °C until HPLC
analysis. A C-20 internal standard curve was constructed for So and
Sa analysis using C-20 as the internal standard.
Samples were resuspended 2 h prior to HPLC analysis with 300 íL
of 85% methanol and 30 íL of ethanol, stirred for 30 s, and sonicated
for 5 min. Twenty microliters of OPA was added, followed by stirring
for 30 s and sonication for 1 min. The samples were kept for 2 h at
room temperature in a dark environment. Samples were transferred to
a 0.45 ím Eppendorf nylon filter tube and centrifuged at 10000 rpm
for 30 s in a microcentrifuge (Beckman Instruments, Inc., Fullerton,
CA). Injection volume was 250 íL. The mobile phase consisted of
HPLC-grade methanol (pump A, 85%) and 1% acetic acid (pump B,
15%). Flow rate was 1 mL/min with a run time of 15 min. The column
used was a C-18 reversed phase Dynamax 50  4.6 mm (Varian,
Walnut Creek, CA) heated at 42 °C. A fluorescence detector was set
at 335 nm emission and 440 nm excitation.
Pathological Evaluation. In the acute toxicity study pigs were
necropsied on day 9, unless euthanized due to poor health or found
dead. In the subacute toxicity study necropsies were performed on day
7. In both studies, pigs were euthanized with a lethal intravenous dose
of 0.5 mL of 7.8% sodium pentobarbital solution. In the subacute
toxicity study, weights of potential target organs liver, lungs, heart,
and kidneys were obtained and compared to final body weight to
construct organ weight/body weight ratios. Tissue samples from organs
were fixed in 10% neutral buffered formalin, processed routinely,
sectioned at 5 ím, and stained with hematoxylin and eosin for
histological evaluation. Additional tissue samples were stored at -20
°C for further sphingolipid extraction.
Statistical Analysis. Within-day comparisons of the least-squares
means of the response variables among the three treatment groups were
made by a repeated measurements analysis using SAS software v. 8.02
(SAS Institute Inc., Cary, NC, 2001). A p value of 0.05 was considered
to be significant except where noted.
RESULTS
In the acute toxicity study, pigs in the FB1 and FB1-G groups
received 11 ímol of FB1/kg of BW. The dose of free unreacted
FB1 in the FB1-G group was 3.3 ímol of FB1/kg of BW,
representing a 70% free amine FB1 reduction. No clinical signs
were observed in any of the pigs on day 1 of the study. Five
pigs in the FB1 group and four in the FB1-G group died from
day 2 through day 6. Eight of the nine pigs died acutely with
clinical signs typical of PPE with duration of <4 h. The ninth
pig, from the FB1 group, was mildly icteric and weak late on
day 6 and was found dead early on day 7. From days 7 to 9,
the remaining pig in the FB1 group and the two remaining in
the FB1-G group were free of clinical signs of PPE except that
one of the FB1-G pigs was moderately depressed with evident
mild icterus of skin, sclera, and mucous membranes. The control
group had the highest weight gain, 1.2 ( 0.1 kg, whereas the
FB1 and FB1-G groups gained an average of 0.5 ( 0.14 and
0.7 ( 0.14 kg, respectively. Weight gains of the FB1 and FB1-G
groups were not statistically different (p < 0.05) (Figure 1).
On day 0 of the acute toxicity study, the serum levels of AST,
GGT, and BIL were similar among the treatment groups (Table
1). CHOL was moderately elevated in FB1 and FB1-G pigs with
respect to controls. On day 3, AST was moderately elevated in
FB1 and FB1-G pigs as compared to controls, GGT levels were
similar among the treatment groups, BIL was moderately
elevated only in FB1 pigs, and CHOL levels were slightly
elevated in FB1 and FB1-G groups with respect to controls (p
< 0.05). The analysis of sphingolipids could not be carried out
in this study because the serum and liver tissue samples stored
for this purpose were lost in a freezer failure.
In the acute toxicity study, five FB1 and four FB1-G pigs
showed characteristic signs of acute PPE, which included
massive hydrothorax with abundant clear straw-colored fluid
high in serum proteins within the thoracic cavity and marked
interstitial pulmonary edema with broad bands of gelatinous
straw-colored fluid separating the major interlobular spaces. One
additional FB1-G pig was determined to have died due to
exanguination into the peritoneal cavity as a probable result of
trauma from ip injection. Necropsy of the remaining pigs in
the FB1 and FB1-G groups revealed no lesions of PPE, although
one pig in the FB1-G group showed mild icterus of skin, sclera,
and mucous membranes.
Figure 1. Comparison of weight gain among the three treatment groups
in the acute (n ) 6) and subacute (n ) 4) studies. The error bar
represents the standard error of the mean (SEM). Different letters above
error bars indicate statistically significant differences between treatment
groups at a given time point (p < 0.05). In both studies, average initial
body weights (day 0) did not differ significantly among the groups.
Table 1. Aspartate Aminotransferase (AST), ç-Glutamyltransferase
(GGT), Total Bilirubin (BIL), and Total Cholesterol (CHOL) Levels in
Serum on Days 0 and 3 of the Acute Toxicity Studya
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL)
Day 0
control 37.8 ± 4.8 a 56.3 ± 5.3 a 0.18 ± 0.01 a 157.5 ± 33.4 a
FB1 51 ± 6.7 a 62.5 ± 7.9 a 0.29 ± 0.04 a 213 ± 13.8 b
FB1-G 42.7 ± 5.9 a 70 ± 13.8 a 0.25 ± 0.04 a 242.3 ± 35.2 b
Day 3
control 54 ± 9.3 a 55.3 ± 2.1 a 0.19 ± 0.01 a 84.7 ± 3.6 a
FB1 191 ± 72.5 b 69.8 ± 7.5 a 1.11 ± 0.33 b 136.8 ± 9.9 b
FB1-G 174.2 ± 62.7 b 76.6 ± 9.7 a 0.48 ± 0.13 a 127.8 ± 17.2 b
a Data are expressed as mean ± SEM. n ) 6. Different letters indicate
statistically significant differences between the group means at a given time point
(p < 0.05). FB1 dose: 11 ímol/kg of BW. Free FB1 in FB1-glucose dose: 3.3
ímol/kg of BW.
7734 J. Agric. Food Chem., Vol. 52, No. 25, 2004 Ferna´ndez-Surumay et al.
In the subacute toxicity study, pigs in the FB and FB1-G
groups received 5.5 ímol of FB1/kg of BW. The dose of free
unreacted FB1 in the FB1-G group was 0.6 ímol of FB1/kg of
BW representing an 89% free amine FB1 reduction. The control
pigs had no apparent signs of disease throughout the duration
of the experiment. Pigs receiving FB1, on the other hand, showed
weakness, rough hair, and lateral recumbency by day 4. Their
condition continued to worsen on a daily basis as they refused
to eat and icterus became evident in the ventral abdominal and
inguinal region of the body and in the ocular sclera. Early on
day 7, one FB1 pig was found dead. Three of four FB1-G pigs
showed rough hair and mild weakness from days 4 to 7, but in
general all pigs in this group were considered to be in good
health until the end of the experiment. Pigs in the control group
had the highest weight gain, 2.02 ( 0.28 kg, whereas pigs in
the FB1 and FB1-G groups gained only 0.2 ( 0.12 and 0.85 (
0.51 kg, respectively. Weight gains of FB1 and FB1-G groups
were not statistically different (p < 0.05, Figure 1).
On day 0 of the subacute toxicity study, the serum levels of
AST, GGT, BIL, and CHOL were similar among the treatment
groups (Table 2). On day 4, the FB1 pigs showed moderately
elevated AST and BIL with respect to controls. GGT levels
were similar among the treatment groups, and CHOL was lower
in controls as compared to FB1 and FB1-G, which shared
moderately elevated levels. AST and BIL were highly elevated
in FB1-treated pigs as compared to controls and FB1-G-treated
pigs on day 7. GGT was higher in the FB1 group but to a lesser
extent. CHOL was higher in FB1 pigs followed by FB1-G and
controls, with all groups different from each other (p < 0.05).
In the subacute toxicity study, serum So levels remained
stable throughout and were not statistically different among the
treatment groups at any time point (Table 3). On day 0, Sa
concentration and the Sa/So ratio were similar between the
treatment groups. On day 4, Sa concentration in FB1 pigs was
greater than in control but similar to that in FB1-G pigs. Control
and FB1-G pig results were not different from each other. The
Sa/So ratio in FB1 pigs was higher than in control but similar
to FB1-G pigs, whereas control and FB1-G pigs had similar
ratios. On day 7, the Sa concentration and Sa/So ratio were
higher in FB1 pigs as compared to control and FB1-G pigs, which
results were not different from each other (p < 0.05). In liver,
So levels in FB1-G pigs were higher than in FB1 and control
pigs (Table 4). FB1 pigs had lower levels of So than control
and FB1-G pigs. The So concentration in control pigs was
intermediate between those of FB1 and FB1-G pigs. Levels of
Sa were higher in FB1 as compared to controls and FB1-G,
which were not different from each other. The Sa/So ratio
followed a trend similar to the Sa concentration (p < 0.05).
Gross inspection of the FB1 pigs in the subacute toxicity study
revealed severe yellow discoloration of subcutaneous, abdomi-
nal, and pericardial fat. Lungs had a normal diffuse pink color,
were not edematous, and had clear airways and trachea. Pale-
yellowish irregular areas could be observed in the liver, which
did not appear to be enlarged. The surface of the kidneys
appeared pale tan to gray and in some cases had a very
congested cortex and very yellow-tinged renal papillae on cut
surface. Serosal surfaces of the gastrointestinal tract appeared
to be mildly congested and edematous but not hemorrhagic.
FB1-G and control pigs showed no obvious icterus and were in
general free of lesions. Microscopic liver changes in the FB1
group consisted primarily of mild to moderate, multifocal
random necrosis of individual hepatocytes or small groups of
hepatocytes with resultant disorganization of hepatic sinusoids.
Hepatocytes individualized, became rounded or hypereosin-
philic, and had pychnotic, karryorrhexic, or karryolytic nuclei.
Mild to moderate karyomegaly was often observed in adjacent
Table 2. Aspartate Aminotransferase (AST), ç-Glutamyltransferase
(GGT), Total Bilirubin (BIL), and Total Cholesterol (CHOL) Levels in
Serum on Days 0, 4, and 7 of the Subacute Toxicity Studya
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL)
Day 0
control 116 ± 33.3 a 40.5 ± 7.3 a 0.3 ± 0.05 a 220.3 ± 22.9 a
FB1 34 ± 2.6 a 42 ± 3.7 a 0.2 ± 0.01 a 218.8 ± 12.4 a
FB1-G 47.2 ± 15 a 45.5 ± 5.3 a 0.9 ± 0.26 a 245.8 ± 18.6 a
Day 4
control 63 ± 19.6 b 43.5 ± 2.7 a 0.2 ± 0.02 a 104 ± 6 a
FB1 201 ± 55 a 74.3 ± 7.3 a 2.3 ± 0.7 b 316.3 ± 71.8 b
FB1-G 48.5 ± 11 b 56.3 ± 8.6 a 0.7 ± 0.23 a 252.5 ± 75.5 b
Day 7
control 47.5 ± 8.4 a 37.3 ± 2.8 a 0.2 ± 0.01 a 85 ± 6.1 a
FB1 1804 ± 661 b 128 ± 26.2 b 7.6 ± 2.13 b 378.8 ± 57.5 b
FB1-G 48.5 ± 6.9 a 48.3 ± 11.7 a 1 ± 0.45 a 274.5 ± 111.4 c
a Data are expressed as mean ± SEM. n ) 4. Different letters indicate
statistically significant differences between the group means at a given time point
(p < 0.05). FB1 dose: 5.5 ímol/kg of BW. Free FB1 in FB1-glucose dose: 0.6
ímol/kg of BW.
Table 3. Sphinganine (Sa) and Sphingosine (So) and Sa/So Ratio in
Serum on Days 0, 4, and 7 of the Subacute Toxicity Studya
Sa (nmol/mL) So (nmol/mL) Sa/So
Day 0
control 0.8 ± 0.2 a 12.4 ± 1.9 a 0.07 ± 0.01 a
(n ) 12) (n ) 12) (n ) 12)
FB1 0.8 ± 0.2 a 9.3 ± 1.2 a 0.08 ± 0.01 a
(n ) 12) (n ) 11) (n ) 12)
FB1-G 0.7 ± 0.08 a 10.5 ± 2.6 a 0.11 ± 0.02 a
(n ) 13) (n ) 13) (n ) 13)
Day 4
control 0.92 ± 0.2 a 8.8 ± 1.2 a 0.11 ± 0.03 a
(n ) 12) (n ) 11) (n ) 12)
FB1 2.77 ± 0.9 b 8.25 ± 1.7 a 0.33 ± 0.07 b
(n ) 12) (n ) 11) (n ) 12)
FB1-G 1.9 ± 0.9 ab 9.88 ± 4.9 a 0.25 ± 0.05 ab
(n ) 11) (n ) 9) (n ) 12)
Day 7
control 1 ± 0.1 a 15.22 ± 2 a 0.05 ± 0.006 a
(n ) 14) (n ) 8) (n ) 16)
FB1 7.67 ± 2.5 b 26.57 ± 5.7 a 0.25 ± 0.07 b
(n ) 10) (n ) 9) (n ) 10)
FB1-G 2.02 ± 0.8 a 18.04 ± 4.1 a 0.1 ± 0.03 a
(n ) 9) (n ) 7) (n ) 9)
a Sphingolipids are expressed as nanomoles per milliliter of serum and expressed
as mean ± SEM. Different letters indicate statistically significant differences between
the group means at a given time point (p < 0.05). FB1 dose: 5.5 ímol/kg of BW.
Free FB1 in FB1-glucose dose: 0.6 ímol/kg of BW.
Table 4. Liver Levels of Sphinganine (Sa) and Sphingosine (So) and
Sa/So Ratio on Day 7 of the Subacute Toxicity Studya
Sa (nmol/g) So (nmol/g) Sa/So
control 0.1 ± 0.05 a 45.1 ± 4.1 ab 0.01 ± 0.008 a
(n ) 8) (n ) 13) (n ) 6)
FB1 13.7 ± 2.1 b 37 ± 12.1 a 1.2 ± 0.4 b
(n ) 12) (n ) 10) (n ) 9)
FB1-G 2.7 ± 0.4 a 71 ± 10.04 b 0.05 ± 0.01 a
(n ) 13) (n ) 12) (n ) 12)
a Sphingolipids are expressed as nanomoles per gram of liver tissue and
expressed as mean ± SEM. Different letters indicate statistically significant
differences between the group means (p < 0.05). Sa/So ratios between control
and FB1 groups were different at a 10% significance level. FB1 dose: 5.5 ímol/kg
of BW. Free FB1 in FB1-glucose dose: 0.6 ímol/kg of BW.
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hepatocytes. A comparison of the three treatment groups is
presented in Figure 2. In the FB1-G group, two of four pigs
showed large, clear, well-demarcated vacuoles in the distal
nephron but were otherwise free of lesions. No microscopic
lesions were observed in control pigs. Ratios of organ weight
to total body weight for heart, lungs, liver, or kidney showed
no significant differences between the treatment groups (data
not shown).
DISCUSSION
The acute toxicity study did not clearly demonstrate reduction
of FB1 toxicity by its reaction with glucose in IP dosing of
swine. This was shown by the death from acute PPE of five of
six pigs in the FB1 group, dosed at 11 ímol of FB1/kg of BW,
and four of six pigs in the FB1-G group, dosed at 3.3 ímol of
FB1/kg of BW. On day 3 weight gains were similar among the
FB1 and FB1-G groups, and the clinical parameters AST and
CHOL were above normal levels (29) and not significantly
different in pigs from these two groups. The toxic effects
observed in this study were consistent with acute FB1 toxicosis
in swine and have been reported by several authors (30-34).
The partial failure of the FB1-glucose adduct in protecting the
pigs in the acute toxicity study from the effects of FB1 could
be explained by the 30% free FB1 in the FB1-G mixture. If this
was the case, FB1-G pigs received an ip dose of 3.3 ímol of
FB1/kg of BW. This dose of FB1 is significantly higher than
the intravenous (iv) dose level of 0.55 ímol of FB1/kg of BW
used by Harrison et al. (35) to characterize acute PPE. It is worth
mentioning that on day 3 of the acute toxicity study, BIL results
in FB1-G pigs were within normal range (29), similar to results
in the control group and lower than in the FB1 group, providing
some evidence of protection of the liver in the FB1-G group
(Table 1).
In contrast to the acute FB1 dose, the subacute toxicity study
revealed reduction of FB1 toxicity in pigs. Only one pig died
from apparent liver damage in the 5.5 ímol of FB1/kg of BW
group, whereas no pigs administered the FB1-glucose products
at a dose of 0.6 ímol of FB1/kg of BW group died. We believe
that two main factors, dose level and amount of free unreacted
FB1 in the FB1-glucose mixture, contributed to the success of
the detoxification treatment in protecting the pigs from FB1-
induced liver damage. The ip dose of 5.5 ímol of FB1/kg of
BW was half the dose used in the acute toxicity study, and the
amount of free unreacted FB1 in the FB1-glucose adduct was
only 11%, meaning that FB1-G pigs received an FB1 dose of
0.6 ímol/kg of BW. The high mortality observed in the FB1-G
pigs of the acute toxicity study, which received 3.3 ímol of
FB1/kg of BW, as compared to the FB1 pigs of the subacute
toxicity study, which received a dose of 5.5 ímol of FB1/kg of
BW, could be explained by the toxicity of the FB1-glucose
products. In preparation for the acute toxicity study, the FB1-
glucose mixture was heated for 48 h, resulting in 70% free amine
FB1 reduction by glucose. Additionally, other reaction products
that were not chemically characterized and of which toxicity
remains unknown may have also been formed. It is likely that
these additional uncharacterized products in the acute toxicity
study may have inhibited the enzyme ceramide synthase in the
pigs treated with FB1-glucose, disrupting the sphingolipid
metabolism and leading to left-sided heart failure and ultimately
PPE. Although in the subacute toxicity study the FB1-glucose
products were prepared following the same method, the mixture
was instead heated for 200 h, resulting in 89% free amine FB1
reduction. The additional FB1-glucose reaction products formed
in the subacute toxicity study were not chemically characterized.
However, we observed that these did not cause any obvious
signs of toxicity in the pigs of the FB1-glucose group. Howard
et al. (36) fed female B6C3F mice 14, 70, and 140 ímol/kg of
diet of several fumonisin derivatives, including FB1 and
N-carboxymethylfumonisin B1, one of the fumonisin B1-
glucose reaction products previously characterized (23, 24). The
study found that only FB1 was hepatotoxic, whereas all other
fumonisin derivatives did not alter serum analytes, organ
weights, or hepatic structure. The high mortality of pigs
administered the FB1-glucose products in the acute toxicity
study as compared to the pigs administered FB1 in the subacute
toxicity study could also be explained by a higher susceptibility
to FB1 exposure. The pigs used in the acute toxicity study were
obtained from a different source than the pigs used in the
subacute toxicity study, possibly having a different genetic
background and a higher susceptibility to FB1 at a 3.3 ímol/kg
of BW dose. In pilot studies not previously published we have
exposed crossbred pigs to levels as high as 145 ímol of FB1/
kg of diet and found no evidence of alteration in AST, GGT,
or BIL. These findings contrast with the results of several studies
(8, 9) that have found liver damage after pigs were fed diets
containing <145 ímol FB1/kg, which leads us to believe that
susceptibility to FB1 could be different in pigs from different
genetic lines. Harrison et al. (35) reported the observation of
pulmonary edema in pigs administered iv pure FB1 at a dose of
0.55 ímol/kg of BW for 4 days, a dose much lower than our ip
dose of 3.3 ímol/kg of BW. Toxicokinetics of pure FB1 after
iv or ip administration appear to be comparable. Shephard et
al. (37) dosed rats ip with 10.4 ímol/kg of BW of 14C-labeled
FB1 and after 24 h recovered 66% of radioactivity in feces and
32% in urine. Prelusky et al. (38) administered iv 14C-labeled
FB1 to pigs at a dose of 0.5 ímol/kg of BW. After 72 h, 58%
of radioactivity was recovered in feces and 21% in urine.
Figure 2. Subacute study: (1) liver from a fumonisin B1-treated pig with multifocal, individual hepatocyte degeneration and necrosis [several degenerate
hepatocytes with pyknotic nuclei (A) and nuclear karyorrhexis (B) are illustrated]; (2) liver from control pig (no significant microscopic lesions were
observed); (3) liver from a fumonisin B1−glucose-treated pig (no significant microscopic lesions were observed). Hematoxylin and eosin stain were used.
Bar ) 30 ím.
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Although in different species, the toxicokinetics results from
these two studies appear to indicate similar excretions of FB1
after either iv or ip administration.
The results of our subacute toxicity study agree with the FB1
data of Haschek et al. (31), in which pure FB1 administered iv
to pigs at 0.0012 and 0.0016 ímol/kg of BW for 9 and 4 days,
respectively, caused mild intermittent respiratory signs but not
pulmonary edema or severe liver damage. Osweiler et al. (8)
also observed subacute hepatotoxicosis in pigs administered iv
0.0011 ímol of FB1/kg of BW for 14 days. Our weight gain
results were equivocal. Pigs in the FB1-G group had a weight
gain similar to that in pigs in the FB1 group. This observation
is because two of four pigs dramatically decreased their feed
consumption on days 4-5 of the study, causing the average
weight gain to drop, whereas the other two pigs consumed as
much feed as the controls (feed consumption data not shown).
Although we could not establish a clear explanation for this
variability, experiment-related stress events may have contrib-
uted to it. We do not believe these two pigs had developed FB1-
glucose adduct-induced feed refusal because two of four pigs
ate well. In FB1 pigs, the liver enzymes AST and GGT started
to show a time-dependent elevation on day 4. By day 7, dramatic
differences in the liver enzyme levels were evident between the
FB1 and control or FB1-G groups. This indicated that liver cells
in the FB1 pigs of the subacute study were severely damaged,
allowing the intracellular enzymes to leak into the bloodstream,
events that presumably did not occur in the control or FB1-G
pigs. These findings are similar to the results of Liu et al. (25),
in which rats exposed to diets containing 0.011 or 0.034 ímol
of FB1/g for 12 or 20 weeks had significantly higher plasma
alanine aminotransferase (ALT) levels than rats fed a basal or
FB1-glucose diet for the same period of time. Our results also
agree with a study by Lu et al. (20) in which rats fed 0.07 ímol
of FB1/g of diet for 4 weeks had a significantly higher ALT
level than rats fed 0.07 ímol of FB1/g of diet reacted with
fructose for the same time. ALT is a specific enzyme for
hepatocellular injury in small species, including the rat (39).
Total cholesterol levels in control pigs showed a time-dependent
decrease, whereas levels in FB1-G pigs remained practically
unchanged during the study. This pattern could explain the
significant differences observed between control and FB1-G pigs
at days 4 and 7 of the subacute study.
Because FB1 disrupts sphingolipid metabolism, results of
individual levels of serum Sa and So and their ratio showed
protection of the FB1-G pigs in the subacute toxicity study. The
levels of Sa, in particular, showed a time-dependent elevation
in the FB1 group throughout the study. On day 7, Sa levels and
the Sa/So ratio were higher in the FB1 pigs as compared to
controls and FB1-G pigs. The higher Sa levels in the FB1 group
were what we expected. Several studies had previously found
a significant elevation of Sa after swine had been fed pure FB1
at 0.002 ímol/g of diet for 5 days (40), FB1 from culture
material at 0.027 ímol/g for 1 day (41), or pure FB1 at 0.013
ímol/g for 8 days (30). In contrast to Riley et al.’s findings
(13), the serum Sa levels in the FB1-treated pigs of our study
did not plateau before day 4, and the serum So levels did not
continue to increase for the duration of the study. The levels of
So were not different among the three groups throughout the
subacute toxicity study, which agrees with the findings of Riley
et al. (13) and Gumprecht et al. (30). Blocking of the primary
amine group of FB1 by its reaction with glucose likely prevented
the inhibition of the enzyme ceramide synthase in the sphingo-
lipids synthesis pathway. Therefore, accumulation of sphingo-
lipid precursors Sa and So was not observed in the FB1-G group.
A similar scenario was observed in liver, where Sa levels were
higher in the FB1 group but not different between controls and
FB1-G, resulting in Sa/So ratios that followed the same pattern.
The results obtained from our FB1-treated pigs were similar to
those of previous studies that have found increased liver Sa,
and to a lesser extent So, and elevated Sa/So ratios in pigs fed
diets containing 0.031 ímol of FB1/g for 14 day (13) or 0.013
ímol of FB1/g for 8 weeks (40). In addition, pharmacokinetic
studies have shown a good correlation between the magnitude
of sphingolipid alterations and the distribution of FB1, which
is highest in liver and kidneys (38).
Gross lesions in the subacute toxicity study agreed with a
study by Colvin et al. (33) in which pigs were daily gavaged
with 5.5 and 22.2 ímol of FB1/kg of BW for 45 and 7 days,
respectively. In that study, pigs were also severely icteric, as
was evident from the bright yellow color of the sclera, oral
mucosa, and subcutaneous adipose tissue. Livers had a tan
coloration. However, the findings of Colvin et al. (33) in kidneys
were different from ours in that they found mild to moderate
renal tubular necrosis and we did not. These researchers reported
that lungs were normal and, although more severe than in our
study, their pigs showed gastrointestinal lesions such as
ulceration and erosion of the nonglandular mucosa. Microscopic
changes consistent with both hepatocyte necrosis and apoptosis
were observed in the FB1 pigs of our subacute toxicity study.
These changes matched those found in several dietary and iv
studies (8, 31, 34). Interestingly, two of our FB1-G pigs had
well-demarcated vacuoles in the distal nephrons. We believe
this represented a random finding because the remaining two
FB1-G pigs did not present such lesions and the other kidney
structures were free of lesions.
In conclusion, in contrast to the acute ip dose of 11 ímol of
FB1/kg of BW, the subacute ip dose of 5.5 ímol of FB1/kg of
BW yielded clear evidence that derivatization of the FB1 amine
with glucose can protect the livers of pigs against the hepatotoxic
effects of FB1. Further studies are necessary to assess the use
of this detoxification strategy in swine feed operations where
quality might be adversely affected by FB1 contamination. Its
implementation in the field will depend on the use of appropriate
processing equipment that would require additional research.
ABBREVIATIONS USED
ALT, alanine aminotransferase; AST, aspartate aminotrans-
ferase; BIL, total bilirubin; C-20, d,l-erythro-C20-dihydro-
sphingosine; CHOL, total cholesterol; DEN, diethylnitrosamine;
ELEM, equine leukoencephalomalacia; FB1, fumonisin B1; FB1-
G, fumonisin B1-glucose; GGT, ç-glutamyltransferase; NEB,
nonenzymatic browning reaction; OPA, o-phthalaldehyde; PPE,
porcine pulmonary edema; Sa, sphinganine; SAP, alkaline
phosphatase; So, sphingosine.
SAFETY
Fumonisin B1 is a class 2B carcinogen and was handled
accordingly.
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